# US 2012/0251467 A1 · Fulvic acid compositions and their use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0251467 A1
- Document ID: US20120251467A1
- Status: Published application
- Kind: A1
- Application number: 13/392,620
- Filed: 2010-08-27
- Published: 2012-10-04
- Earliest claimed: 2009-08-27
- Inventors: Stephen William Leivers
- Web page: https://patentgrep.com/patent/US20120251467A1

## CPC

- A61K 31/352: condensed with carbocyclic rings, e.g. methantheline {(cannabinoids A61K31/658)}
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Carbohydrate-derived fulvic acid (CHD-FA), a salt, ester or derivative thereof for use in the prevention, treatment or inhibition of infection by oral pathogens in a mammal, compositions, particularly compositions suitable for oral administration, comprising the same.

## Claims

### Claim 1

An oral pharmaceutical composition for preventing, treating or inhibiting an infection by an oral pathogen, comprising:
(a) carbohydrate-derived fulvic acid (CHD-FA), a salt, ester or derivative thereof as active ingredient; and
(b) a pharmaceutically acceptable carrier for oral administration of the active ingredient.

### Claim at position 2

-3. (canceled)

### Claim 4 (depends on 3)

The pharmaceutical composition according to claim 3, in which the active ingredient is present in an amount from about 8% to 60% v/v of the composition.

### Claim 5 (depends on 4)

The pharmaceutical composition according to claim 4, in which the active ingredient is present in an amount of about 35% v/v of the composition.

### Claim 6

(canceled)

### Claim 7 (depends on 1)

The pharmaceutical composition according to claim 1 that is formulated as a mouthwash, a toothpaste, an impregnated dental floss or dental tape, or an endodontic irrigant.

### Claim at position 7

-12. (canceled)

### Claim 13 (depends on 1)

The pharmaceutical composition according to claim 1, further comprising a flavorant.

### Claim 14

A method of preventing, treating or inhibiting infection by an oral pathogen in a mammalian subject in need thereof, comprising administering to the subject an effective amount of a pharmaceutical composition that comprises:
(a) CHD-FA, or a salt, ester or derivative thereof; and
(b) a pharmaceutically acceptable carrier for oral administration.

### Claim 15 (depends on 14)

The method according to claim 14, wherein the subject is a human.

### Claim 16 (depends on 14)

The method according to claim 14, wherein the infection is in the form of an oral biofilm.

### Claim 17 (depends on 14)

The method according to claim 14, wherein the CHD-FA, or the salt, ester or derivative thereof is present in an amount from about 8% to 60% v/v of the composition.

### Claim 18 (depends on 14)

The method according to claim 14, wherein the CHD-FA, or the salt, ester or derivative thereof is present in an amount of about 35% v/v of the composition.

### Claim 19 (depends on 14)

The method according to claim 14, wherein the pharmaceutical composition further comprises a flavorant.

### Claim 20 (depends on 14)

The method according to claim 14, wherein the pharmaceutical composition is formulated as a mouthwash and is administered by rinsing the oral cavity with the mouthwash.

### Claim 21 (depends on 14)

The method according to claim 14, wherein the pharmaceutical composition is formulated as a toothpaste and is administered by brushing the teeth with the toothpaste.

### Claim 22 (depends on 14)

The method according to claim 14, wherein the pharmaceutical composition is formulated as impregnated dental floss or dental tape and is administered by flossing of teeth and gums.

### Claim 23 (depends on 14)

The method according to claim 14, wherein the pharmaceutical composition is formulated as an endodontic irrigant administered as part of an endodontic procedure.
